Neuronal nicotinic receptors: from structure to pathology
C Gotti, F Clementi - Progress in neurobiology, 2004 - Elsevier
Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are
differently expressed in many regions of the central nervous system (CNS) and peripheral …
differently expressed in many regions of the central nervous system (CNS) and peripheral …
[HTML][HTML] Nicotinic acetylcholine receptors in neurological and psychiatric diseases
AV Terry Jr, K Jones, D Bertrand - Pharmacological Research, 2023 - Elsevier
Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that are
widely distributed both pre-and post-synaptically in the mammalian brain. By modulating …
widely distributed both pre-and post-synaptically in the mammalian brain. By modulating …
SiRNA delivery with exosome nanoparticles
JG Van den Boorn, M Schlee, C Coch… - Nature …, 2011 - nature.com
SiRNA delivery with exosome nanoparticles | Nature Biotechnology Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease
RG Nagele, MR D'andrea, WJ Anderson, HY Wang - Neuroscience, 2002 - Elsevier
Amyloid β1–42, a major component of amyloid plaques, binds with exceptionally high affinity
to the α7 nicotinic acetylcholine receptor and accumulates intracellularly in neurons of …
to the α7 nicotinic acetylcholine receptor and accumulates intracellularly in neurons of …
Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimer's disease
HY Zhang, SJ Wang, J Xing, B Liu, ZL Ma… - Behavioural brain …, 2009 - Elsevier
Resting-state networks dissociate in the early stage of Alzheimer's disease (AD). The
posterior cingulate cortex (PCC) in AD brain is vulnerable to isolation from the rest of brain …
posterior cingulate cortex (PCC) in AD brain is vulnerable to isolation from the rest of brain …
Cognitive improvement by activation of α7 nicotinic acetylcholine receptors: from animal models to human pathophysiology
MS Thomsen, HH Hansen… - Current …, 2010 - ingentaconnect.com
Agonists and positive allosteric modulators of the α7 nicotinic acetylcholine receptor
(nAChR) are currently being developed for the treatment of cognitive disturbances in …
(nAChR) are currently being developed for the treatment of cognitive disturbances in …
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease
The association between nicotinic acetylcholine receptor (nAChR) dysfunction and cognitive
decline in Alzheimer's disease (AD) has been widely exploited for its therapeutic potential …
decline in Alzheimer's disease (AD) has been widely exploited for its therapeutic potential …
All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis
J Modregger, B Ritter, B Witter… - Journal of cell …, 2000 - journals.biologists.com
The PACSINs are a family of cytoplasmic phosphoproteins that play a role in vesicle
formation and transport. We report the cloning and cDNA sequencing of PACSIN 3 and the …
formation and transport. We report the cloning and cDNA sequencing of PACSIN 3 and the …
Alzheimer's disease amyloid β-protein and synaptic function
T Ondrejcak, I Klyubin, NW Hu, AE Barry… - Neuromolecular …, 2010 - Springer
Alzheimer's disease (AD) is characterized neuropathologically by the deposition of different
forms of amyloid β-protein (Aβ) including variable amounts of soluble species that correlate …
forms of amyloid β-protein (Aβ) including variable amounts of soluble species that correlate …
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons
MR D'Andrea, RG Nagele - Current pharmaceutical design, 2006 - ingentaconnect.com
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …
disease (AD), the development of new drugs that target pathological features that appear …